Canine Cancer: Strategies in Experimental Therapeutics

by Douglas H. Thamm, Douglas H. Thamm, Douglas H. Thamm
Published 2019-11-01

Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy

by Erica A. Faulhaber, Emily Janik, Douglas H. Thamm
Published 2021-07-01

Bisphosphonate conjugation for bone specific drug targeting

by Kristen B. Farrell, Alexander Karpeisky, Douglas H. Thamm, Shawn Zinnen
Published 2018-12-01

Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy

by Kazuki Heishima, Travis Meuten, Kyoko Yoshida, Takashi Mori, Douglas H. Thamm
Published 2019-01-01

In vitro antineoplastic effects of auranofin in canine lymphoma cells

by Hong Zhang, Barbara J. Rose, Alex A. Pyuen, Douglas H. Thamm
Published 2018-05-01

In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.

by Alex A Pyuen, Travis Meuten, Barbara J Rose, Douglas H Thamm
Published 2018-01-01

Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma

by Douglas H. Thamm, Jenette K. Joseph, Barbara J. Rose, Travis K. Meuten, Kristen M. Weishaar
Published 2020-03-01

DNA repair deficiency as a susceptibility marker for spontaneous lymphoma in golden retriever dogs: a case-control study.

by Douglas H Thamm, Kristen K Grunerud, Barbara J Rose, David M Vail, Susan M Bailey
Published 2013-01-01

Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling

by Hongxiu Diao, Nan Cheng, Ying Zhao, Huihao Xu, Haodi Dong, Douglas H. Thamm, Di Zhang, Degui Lin
Published 2019-08-01

Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines.

by Junko Maeda, Coral E Froning, Colleen A Brents, Barbara J Rose, Douglas H Thamm, Takamitsu A Kato
Published 2016-01-01

A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells

by Tae Hyun Kim, Yang Wang, C. Ryan Oliver, Douglas H. Thamm, Laura Cooling, Costanza Paoletti, Kaylee J. Smith, Sunitha Nagrath, Daniel F. Hayes
Published 2019-04-01

Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs

by Jacob R. Cawley, Zachary M. Wright, Karri Meleo, Gerald S. Post, Craig A. Clifford, Kathryn R. Vickery, David M. Vail, Philip J. Bergman, Douglas H. Thamm
Published 2020-03-01

Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs

by Sabina I. Hlavaty, Yu-Mei Chang, Rachel P. Orth, Mark Goulian, Paul J. Planet, Paul J. Planet, Douglas H. Thamm, Jennifer A. Punt, Oliver A. Garden
Published 2019-10-01

Comparative oncology approach to drug repurposing in osteosarcoma.

by Alejandro Parrales, Peter McDonald, Megan Ottomeyer, Anuradha Roy, Frank J Shoenen, Melinda Broward, Tyce Bruns, Douglas H Thamm, Scott J Weir, Kathleen A Neville, Tomoo Iwakuma, Joy M Fulbright
Published 2018-01-01

Genomic instability and telomere fusion of canine osteosarcoma cells.

by Junko Maeda, Charles R Yurkon, Hiroshi Fujisawa, Masami Kaneko, Stefan C Genet, Erica J Roybal, Garrett W Rota, Ethan R Saffer, Barbara J Rose, William H Hanneman, Douglas H Thamm, Takamitsu A Kato
Published 2012-01-01

Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.

by Hong Zhang, Hongxiu Diao, Lixin Jia, Yujing Yuan, Douglas H Thamm, Huanan Wang, Yipeng Jin, Shimin Pei, Bin Zhou, Fang Yu, Linna Zhao, Nan Cheng, Hongchao Du, Ying Huang, Di Zhang, Degui Lin
Published 2017-01-01